Regional News Archives - Page 165 of 189 - Journal for Clinical Studies

Current Edition

Europe

Cristal Therapeutics Initiates Phase 2 Clinical Trial of Innovative CriPec® Nanomedicine Drug Candidate in Ovarian Cancer

Maastricht, The Netherlands, October 25, 2018 / B3C newswire / -- Cristal Therapeutics, a clinical stage pharmaceutical company developing unique nanomedicines for th...

1 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Retrospective Study Featuring OSSDSIGN® Cranial Published in World Neurosurgery

UPPSALA, Sweden, October 29, 2018 (Newswire.com) - OssDsign AB, the Swedish designer, manufacturer and distributor of regenerative implants for cranial and facial rec...

1 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Pivotal Trial Confirms Long-Term Safety and Efficacy of IV Iron Dosing Strategy

Results from the PIVOTAL trial were presented during the High-Impact Clinical Trials session at American Society of Nephrology (ASN) Kidney Week 2018 The tria...

1 November 2018 Europe | news | North America | Regional News

Continue Reading →

Europe

Genmab Announces Positive Topline Results in Phase III MAIA Study of Daratumumab in Front Line Multiple Myeloma

Phase III MAIA study of daratumumab in combination with lenalidomide and dexamethasone in front line multiple myeloma met the primary endpoint (PFS) at a pre-plann...

1 November 2018 Europe | news | Regional News

Continue Reading →

Europe

Targeted drugs for advanced cancer move from specialist units to community setting

Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centres in the US, are receiving innovative drugs matched to DNA muta...

25 October 2018 Europe | news | Regional News

Continue Reading →

Europe

Immunotherapy may become new first line treatment in some metastatic colorectal cancers

Immunotherapy with nivolumab and low-dose ipilimumab could become a new first line treatment in patients with some metastatic colorectal cancers following late-breaki...

25 October 2018 Europe | news | North America | Regional News

Continue Reading →

news

FDA approves asthma indication for Dupixent® (dupilumab)

Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype Only biologic approved for oral corticosteroid-dependent asthma, ...

25 October 2018 news | North America | Regional News

Continue Reading →

Europe

Polyganics Initiates First-in-Human Trial of LIQOSEAL®, its Innovative Approach for Dural Closure

Groningen, The Netherlands, October 22, 2018 / B3C newswire / -- Polyganics, a medical technology company developing, manufacturing and commercializing bioresorbable ...

25 October 2018 Europe | news | Regional News

Continue Reading →

Europe

Genmab Announces Positive Topline Results in Phase III CASSIOPEIA Study of Daratumumab in Front Line Multiple Myeloma

Phase III CASSIOPEIA study of daratumumab in combination with bortezomib, thalidomide and dexamethasone in front line multiple myeloma met the primary endpoint of ...

25 October 2018 Europe | news | Regional News

Continue Reading →

Europe

Nanobiotix: Positive Phase II / III Results for NBTXR3 in Soft Tissue Sarcoma Presented at ESMO

Dr. Sylvie Bonvalot, Head of Sarcoma and Complex Tumor Surgery Unit at Institut Curie - Paris, presented first-in-class NBTXR3 positive Phase II/III results during...

25 October 2018 Europe | news | North America | Regional News

Continue Reading →